GENTAG Announces Wireless Diagnostic Skin Patch Patent

WASHINGTON, /PRNewswire/ -- GENTAG, Inc. is pleased to announce the recent issuance of US Patent 7,969,307, complementing its joint patent portfolio with Motorola, including US Patents 7,148,803; 7,492,254; and pending foreign PCT applications covering disposable wireless sensors compatible with cell phones, including Near Field Communication (NFC) cell phones.

Patent 7,969,307 covers disposable wireless skin patches directly readable with NFC cell phones, as well as other disposable NFC sensors for consumer applications, including medication, food safety, pathogen detection, cosmetics, and M2M markets.

With its combination of proprietary technologies and issued patents, GENTAG, Inc. is in a unique position to capitalize on the emerging global market of consumer-based cell phone sensor transactions, overlaying precise in-building geolocation (US Patent 6,031,454), NFC sensor transactions and web-based transactions. "Our technologies will allow Groupon-type cell phone transactions for any consumer market or application," indicated Dr. John P. Peeters, the founder of GENTAG. "We look forward to bringing this technology to consumers worldwide via our existing and future partners."

Patent 7,969,307 is assigned to Altivera, LLC, a GENTAG holding company. Recent patent acquisitions in the area of wireless have averaged $750,000 per patent.

About GENTAG
GENTAG, Inc. is a technology development company focusing on the creation of innovative, low-cost, wireless sensor technologies based on cell phones. The company owns a unique intellectual property portfolio relating to cell-phone sensor combinations, geolocation technologies and wireless sensor networks and was awarded a Frost & Sullivan North American Award for Technology Innovation.

Suggested Articles

AMD and Nvidia saw 6% drop, joining long list of losers

Semtech Corp. has introduced LoRa Edge, a low power, software defined LoRa-based platform.

Interconnections supplier Amphenol Corp. has downgraded its Q1 2020 fiscal guidance due to coronavirus effects on its business.